Insulin resistance and systemic inflammation synergistically increased the risk of cardiovascular events in patients with diabetic chronic coronary syndrome.
Does the combination of insulin resistance and systemic inflammation increase the risk of cardiovascular events in diabetic CCS patients?
Combining TyG and hsCRP can help identify high-risk diabetic CCS patients, as insulin resistance and systemic inflammation synergistically increase cardiovascular risk.
Absolute Event Rate: 0% vs 0%
< 0.001). In diabetic CCS patients, insulin resistance and systemic inflammation synergically increased the risk of cardiovascular events, and systemic inflammation partially mediated the association between insulin resistance and clinical outcomes. Combining TyG and hsCRP can help identify high-risk patients. Controlling inflammation in patients with insulin resistance may bring added benefits.
Li et al. (Mon,) reported a other. Insulin resistance and systemic inflammation synergistically increased the risk of cardiovascular events in patients with diabetic chronic coronary syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: